Michael H. Goldstein Ocular Therapeutix, Inc (OCUL) insider trading activity
Michael H. Goldstein is President, Ophthalmology & CMO of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 313,335 shares of OCUL, which is worth approximately $2.61 Million. The most recent transaction as insider was on Feb 03, 2022, when has been sold 63,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
313K
0%
3M change
0%
12M change
Total Value Held
$2.61 Million
MHG
Michael H. Goldstein
President, Ophthalmology & CMO
Bedford,, MA